Melanogenesis Inhibitor(s) from Phyla nodiflora Extract

Area of Science:

• Dermatology
• Pharmacology
• Molecular Biology

Background:

• Tyrosinase overexpression leads to hyperpigmentation disorders like melasma and freckles.
• Plant-derived agents are explored for downregulating tyrosinase and melanin production.
• Phyla nodiflora Greene (Verbenaceae) is a Taiwanese folk medicine with anti-inflammatory uses, but its antimelanogenesis effects are unstudied.

Purpose of the Study:

• To investigate the antimelanogenesis activity of the methanolic extract of Phyla nodiflora (PNM).
• To elucidate the molecular mechanisms underlying PNM's effects on melanogenesis.

Main Methods:

• Assessed cytotoxicity of PNM on cells.
• Measured cellular melanin content and tyrosinase activity.
• Analyzed the expression of key proteins involved in melanogenesis, including MITF, TRP-1, TRP-2, and phosphorylated MAP kinases (ERK, JNK, p38).

Main Results:

• PNM significantly reduced cellular melanin content and tyrosinase activity in a dose-dependent manner without cytotoxicity.
• PNM decreased levels of phospho-cAMP response element-binding protein and MITF, inhibiting tyrosinase, TRP-1, and TRP-2 synthesis.
• PNM activated MAPK phosphorylation (ERK, JNK, p38), leading to MITF inhibition and reduced melanogenesis.

Conclusions:

• PNM exhibits significant antimelanogenesis effects by modulating key molecular pathways.
• PNM demonstrates potential as a safe and effective cosmetic agent for skin whitening and treating hyperpigmentation.